A detailed history of Ameriprise Financial Inc transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 143,807 shares of PTGX stock, worth $5.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
143,807
Holding current value
$5.84 Million
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$33.72 - $47.33 $4.85 Million - $6.81 Million
143,807 New
143,807 $6.46 Million
Q2 2023

Aug 14, 2023

BUY
$18.02 - $29.36 $1.47 Million - $2.39 Million
81,572 Added 444.34%
99,930 $2.76 Million
Q1 2023

May 15, 2023

BUY
$10.78 - $25.38 $197,899 - $465,926
18,358 New
18,358 $422,000
Q2 2021

Aug 16, 2021

SELL
$25.57 - $44.88 $728,438 - $1.28 Million
-28,488 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$19.02 - $31.15 $729,740 - $1.2 Million
-38,367 Reduced 57.39%
28,488 $737,000
Q4 2020

Feb 12, 2021

BUY
$18.49 - $25.13 $1.24 Million - $1.68 Million
66,855 New
66,855 $1.35 Million

Others Institutions Holding PTGX

About Protagonist Therapeutics, Inc


  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $1.99B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.